Scholar Rock Holding Corporation
NASDAQ:SRRKBiotechnology
+$0.49 today
- Market cap
- $5.86B
- Beta
- 0.69
- P/E (TTM)
- -14.8
- EPS (TTM)
- -$3.21
Volume 2.77M
Average 1.46M
SRRK Interest Income
Income earned on cash, deposits, and investments held by the company.
Scholar Rock Holding CorporationNASDAQ: SRRK
Interest Income · Q3 FY2026 · quarter ended Sep 2026
Interest income grows, but more slowly than its trailing trend
Q3 FY2026 interest income of $4.1M rose 49.9% year over year, behind the +138.4% change in trailing-twelve-month interest income. Sequentially, it rose 0.1% from the prior quarter.
Context
- Interest income increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +49.9% toward the trailing-twelve-month pace of +138.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Income history
USD · from the income statement
- Latest · FY2025
- 13.9M USD
- Year-over-year change
- +9.6%
| Period | Period end | Interest Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 13.9M | +9.6% |
| FY2024 | 2024-12-31 | 12.68M | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Interest Income vs competitors
How SRRK compares with its peers on the latest reported figures
- SRRK's LTM Sep 2026 interest income of $14.65M is the 8th highest of the 11 companies compared; the peer median is $31.16M.
- Its year-over-year change of +138.4% is the highest of 10, against a peer median of +6.8%.
- Interest income amounts to 2570.2% of revenue for SRRK, versus a peer median of 9.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $89.99M | -11.7% | +56.9% | 9.4% | |
| LTM Sep 2026 | $36.88M | +19.3% | +45.5% | — | |
| LTM Jun 2026 | $32.68M | +6.8% | +117.1% | — | |
| LTM Sep 2026 | $31.98M | +34.8% | +106.9% | — | |
| LTM Jun 2026 | $31.41M | -30.6% | — | 20.1% | |
| LTM Mar 2026 | $30.91M | -51.9% | -11.0% | 1.4% | |
| LTM Jun 2026 | $23.48M | +36.0% | +38.1% | 3.3% | |
| LTM Sep 2026 | $14.65M | +138.4% | — | 2570.2% | |
| LTM Mar 2026 | $12.38M | +77.1% | +79.8% | 61.9% | |
| LTM Mar 2026 | $10.88M | -17.0% | +64.0% | 33.9% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding SRRK) | $31.16M | +6.8% | +60.4% | 9.4% | |
Competitors are the stored peer set for SRRK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 18.82M | 33.19M | 0 | 0 | 0 |
| Cost of Revenue | 108.47M | 123.04M | 2.84M | 1.94M | 208.44M |
| Gross Profit | (89.65M) | (89.85M) | (2.84M) | (1.94M) | (208.44M) |
| Gross Margin | -476.5% | -270.7% | — | — | — |
| Research & Development | 108.47M | 124.44M | 119.06M | 182.61M | 208.44M |
| Selling, General & Admin | 40.27M | 42.62M | 49.4M | 67.5M | 176.21M |
| Operating Expenses | 40.27M | 44.52M | 168.45M | 250.12M | 176.21M |
| Depreciation & Amortization | 2.63M | 2.99M | 2.84M | 1.94M | 1.66M |
| EBITDA | (129.17M) | (129.48M) | (162.95M) | (237.52M) | (369.39M) |
| EBITDA Margin | -686.5% | -390.1% | — | — | — |
| Operating Income | (129.92M) | (134.37M) | (171.3M) | (252.05M) | (384.65M) |
| Operating Margin | -690.5% | -404.8% | — | — | — |
| Interest Income | 0 | 0 | 0 | 12.68M | 13.9M |
| Interest Expense | 0 | 0 | 0 | 6.84M | 6.89M |
| Other Income / Expenses | (1.88M) | (132K) | 5.51M | 5.76M | 6.71M |
| Income Before Tax | (131.8M) | (134.5M) | (165.79M) | (246.29M) | (377.94M) |
| Pre-Tax Margin | -700.5% | -405.2% | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (131.8M) | (134.5M) | (165.79M) | (246.29M) | (377.94M) |
| Net Margin | -700.5% | -405.2% | — | — | — |
| EPS (Basic) | (3.59) | (2.21) | (1.99) | (2.47) | (3.29) |
| EPS (Diluted) | (3.59) | (2.21) | (1.99) | (2.47) | (3.29) |
| Weighted Avg Shares | 36.71M | 59.61M | 75.98M | 99.84M | 114.7M |
| Weighted Avg Shares (Diluted) | 36.71M | 59.61M | 75.98M | 99.84M | 114.7M |
Scholar Rock Holding Corporation
NASDAQ:SRRK
Intrinsic Alpha fair value
Locked
Current Price
$48.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.